NeuroPace, Inc.NPCENASDAQ
Loading
Year-over-year research & development expense growth
3Y CAGR
-4.4%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 17.90% |
| 2024 | 13.84% |
| 2023 | -5.32% |
| 2022 | 20.51% |
| 2021 | 16.03% |
| 2020 | -14.21% |
| 2019 | 0.00% |